Coronavirus cure vaccine: Australian researchers begin testing
The CSIRO said that it has commenced the first stage of testing at the Australian Animal Health Laboratory (AAHL) in Geelong, 75 km southwest of Melbourne, reports Xinhua news agency.
Researchers from Australia`s Commonwealth Scientific and Industrial Research Organization (CSIRO) on Thursday announced that they have begun testing vaccines for the novel coronavirus.
The CSIRO said that it has commenced the first stage of testing at the Australian Animal Health Laboratory (AAHL) in Geelong, 75 km southwest of Melbourne, reports Xinhua news agency.
The trials are expected to take three months and will be conducted on ferrets to determine if either of the two vaccines were safe and effective.
"Beginning vaccine candidate testing at CSIRO is a critical milestone in the fight against COVID-19, made possible by collaboration both within Australia and across the globe," Larry Marshall, the Chief Executive of the CSIRO, said in a statement.
"CSIRO researchers are working around-the-clock to combat this disease which is affecting so many -- whether it`s at the AAHL or at our state-of-the-art biologics manufacturing facility -- we will keep working until this viral enemy is defeated," he added.
Watch Zee Business live TV below:
Even if the vaccines were found to be effective and safe, it could take 12 to 18 months for them to be rolled out around the world.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Mukhyamantri Majhi Ladki Bahin Yojana: Know eligibility, benefits, and documents to apply for this women-centric government scheme
Gratuity Calculator: Rs 37,000 as last-drawn salary; 6 years and 3 months as service period; know your gratuity?
Top 7 Gold ETFs With Highest Annualised Returns in 10 Years: Know how Rs 10 lakh investment in each ETF has performed in last decade
Defence PSU Stock to BUY: This multibagger scrip corrects 49% from 52-week high - Is this right time to buy?
Top 7 Large and Mid Cap Mutual Funds With up to 43% Return in 1 Year: Rs 25,000 monthly SIP investment in No. 1 scheme is now worth Rs 3,64,654
Power of Compounding: Can monthly SIP investment of Rs 7,000 help build corpus of Rs 4.5 crore? See in how many years it can be done
02:44 PM IST